The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 5654 -5662
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803942

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dale, B. M.
Right arrow Articles by Greenberg, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dale, B. M.
Right arrow Articles by Greenberg, S.

Phagocytosis in Macrophages Lacking Cbl Reveals an Unsuspected Role for Fc{gamma} Receptor Signaling and Actin Assembly in Target Binding1

Benjamin M. Dale*, Daniel Traum{dagger}, Hediye Erdjument-Bromage{ddagger}, Paul Tempst{ddagger} and Steven Greenberg2,3,*,{dagger}

* Department of Pharmacology and {dagger} Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Columbia University College of Physicians & Surgeons, New York, NY, 10032; and {ddagger} Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, and Weill Graduate School of Medical Sciences, Cornell University, New York, NY 10021

Fc{gamma} receptor (Fc{gamma}R)-mediated phagocytosis is known to require tyrosine kinases (TKs). We identified c-Cbl and Cbl-b as proteins that undergo tyrosine phosphorylation during phagocytosis. Cbl-deficient macrophages displayed enhanced Fc{gamma}R-mediated signaling and phagocytosis. Surprisingly, binding of IgG-coated targets (EIgG) was also enhanced. c-Cbl-deficient macrophages expressed less Fc{gamma}RIIb, the inhibitory Fc{gamma} receptor; however, this did not account for enhanced target binding. We isolated the function of one Fc receptor isoform, Fc{gamma}RI, using IgG2a-coated targets (EIgG2a). Cbl-deficient macrophages demonstrated a disproportionate increase in binding EIgG2a, suggesting that signal strength regulates binding efficiency toward opsonized targets. In resting cells, Fc{gamma}RI colocalized with the Src family TK Hck in F-actin-rich structures, which was enhanced in Cbl-deficient macrophages. Target binding was sensitive to TK inhibitors, profoundly inhibited following depletion of cholesterol, and ablated at 4°C or in the presence of inhibitors of actin polymerization. Sensitivity of EIgG binding to cytoskeletal disruption was inversely proportional to opsonin density. These findings challenge the view that Fc{gamma}R-mediated binding is a passive event. They suggest that dynamic engagement of TKs and the cytoskeleton enables macrophages to serve as cellular "Venus fly traps", with the capacity to capture phagocytic targets under conditions of limiting opsonin density.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants HL054164 and AI067502 to S.G.

2 Current address: Merck Research Laboratories, 126 East Lincoln Avenue, RY34B-348, Rahway, NJ 07065.

3 Address correspondence and reprint requests to Dr. Steven Greenberg, Merck Research Laboratories, 126 East Lincoln Avenue, RY34B-348, Rahway, NJ 07065. E-mail address: smg8{at}columbia.edu

4 Abbreviations used in this paper: TK, tyrosine kinase; BMDM, bone marrow-derived macrophages; EIgG, IgG-coated erythrocytes; WT, wild type.

5 The online version of the article contains Extended Methods.

6 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.